DrugDashboards
← Home
Manufacturing facility

Novocol Pharmaceutical of Canada, Inc.

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
Canada
Registered address
25 Wolseley Crt, Cambridge, Ontario N1R 6X3, Canada (CAN)
Operations here
manufacture
FDA identifiers
FEI 3002807757 · DUNS 201719960

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2024-05-03
  • NAIBioresearch Monitoring2020-01-30
  • NAIBioresearch Monitoring2019-06-21
  • VAIDrug Quality Assurance2019-06-18
  • VAIBioresearch Monitoring2017-07-26
  • VAIDrug Quality Assurance2017-05-16
  • VAIDrug Quality Assurance2015-08-11
  • VAIDrug Quality Assurance2014-11-11
  • VAIDrug Quality Assurance2012-04-20
  • VAIDrug Quality Assurance2010-10-22
  • VAIPostmarket Surv. and Epidemiology2010-10-22

Drugs this plant is listed as making

13 distinct drugs across 50 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.